Transcultural and Psychometric Validation of SUSHI and HOOS-12 Scores in Patients With Coxofemoral Pathologies (HIP)

The management of coxofemoral pathologies is constantly increasing.

In addition to degenerative hip pathology, the orthopedic surgeon is now confronted with pathologies such as femoro-acetabular conflict, pathologies of the gluteus medius and pathologies of the labrum whose early management limits arthritis degeneration. These pathologies are mainly encountered in young subjects (<60 years).

Self-questionnaires play an important role in understanding patients' point of view on the impact of their coxofemoral pathologies and also allow an assessment of their condition after treatment.

For the evaluation of coxofemoral pathologies in the young subject (<60 years) the Super Simple Hip score (SUSHI-score) was developed and validated.

In the elderly subject with hip osteoarthritis, the HOOS score has the advantage of specifically measuring pain, symptoms, function and quality of life, but is made up of 40 items and is often considered rather heavy to submit. However, it has recently been simplified and the HOOS-12 (HOOS score with 12 items) has been developed and validated.

These two scores are useful in current clinical practice but they are only validated in English.

Study Overview

• Status: Recruiting
• Conditions: Coxofemoral Pathologies
• Intervention / Treatment: Other: Self-assessment questionnaires

• Study Type: Observational
• Enrollment (Anticipated): 120

Contacts and Locations

• Study Contact: Name: Mathieu SEVERYNS, MD; Phone Number: +596 05 96 55 22 21; Email: mathieu.severyns@chu-martinique.fr

Study Locations

• France
  • Paris, France, 75010
    • Recruiting
    • Hôpital Lariboisière - AP-HP
    • Contact: Guillaume ODRI, MD; Phone Number: +33 01 49 95 91 51; Email: guillaume.odri@ap-hp.fr
    • Principal Investigator: Guillaume ODRI, MD
  • Saint-Grégoire, France, 35760
    • Recruiting
    • Centre Hospitalier Prive Saint-Gregoire
    • Contact: Charles KAJETANEK, MD; Phone Number: +33 02 23 25 30 85; Email: charles.kajetanek@gmail.com
    • Principal Investigator: Charles Kajetanek, MD
• Martinique
  • Fort-de-France, Martinique, 97261
    • Recruiting
    • CHU of Martinique
    • Contact: Mathieu SEVERYNS, MD; Phone Number: +596 05 96 55 22 21; Email: mathieu.severyns@chu-martinique.fr
    • Principal Investigator: Mathieu SEVERYNS, MD
    • Sub-Investigator: Lucas MATTESI, MD

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 18 years and older (Adult, Older Adult)
• Accepts Healthy Volunteers: No
• Genders Eligible for Study: All

• Sampling Method: Probability Sample

Study Population

Patients with a coxofemoral pathology.

Description

Inclusion Criteria:

• Adult patient (age greater than or equal to 18 years old),
• Patient with coxofemoral pathology,
• Patient having been informed of the research,
• Patient agreeing to participate in the study.

Exclusion Criteria:

• Minor patient,
• Pregnant woman,
• Patient out of state to agree to participate in the study,
• Patient unable to answer a self-assessment questionnaire,
• Patient under justice, guardianship or curatorship,
• Patient who refused to participate in the study.

Study Plan

How is the study designed?

Design Details

• Observational Models: Cohort
• Time Perspectives: Prospective

Number of groups / cohorts

1

Cohorts and Interventions

Group / Cohort

Intervention / Treatment

Patients with coxofemoral pathologies; For the transcultural validation, a french version of the 2 self-assessment questionnaires, SUSHI-score and the HOOs-12 score will be produced. For the psychometric validation, 120 patients with coxofemoral pathologies will pass the two questionnaires. The HAGOS (Hip and Groin Score) questionnaire will be also passed by the subject, for the convergent validity.

Other: Self-assessment questionnaires; 120 patients with coxofemoral pathologies will pass the SUSHI-score and the HOOS-12 score questionnaires. The HAGOS (Hip and Groin Score) questionnaire will be also passed by the subject, for the convergent validity.

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Transcultural validation of the SUSHI-score and HOOS-12 score questionnaire	It will be a question of obtaining a version translated into French. The translated version tested on a small group of patients (15) will be submitted to the author of the original version of the tool, along with a report highlighting and explaining all the modifications and difficulties noted by a group of experts.	1 month
Psychometric validation of the SUSHI-score and HOOS-12 score questionnaire	Questionnaires will be passed by 120 subjects. Following parameters will be measured: feasibility and acceptability, validity, reliability, and sensitivity to change.	12 months

Collaborators and Investigators

• Sponsor: University Hospital Center of Martinique
• Collaborators: Saint-Gregoire Private Hospital Center; Lariboisière Hospital

Study record dates

Study Major Dates

• Study Start (Actual): September 11, 2020
• Primary Completion (Anticipated): September 1, 2022
• Study Completion (Anticipated): March 1, 2023

Study Registration Dates

• First Submitted: July 9, 2020
• First Submitted That Met QC Criteria: July 9, 2020
• First Posted (Actual): July 14, 2020

Study Record Updates

• Last Update Posted (Actual): June 13, 2022
• Last Update Submitted That Met QC Criteria: June 10, 2022
• Last Verified: December 1, 2021

More Information

Terms related to this study

• Keywords: Psychometric validation; Coxofemoral pathologies; Self assessment questionnaire; Super Simple Hip score (SUSHI-score); Hip disability and Osteoarthritis Outcome Score (HOOS score); Transcultural validation; Hip and Groin score (HAGOS)
• Other Study ID Numbers: 20_RIPH3-03

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: No

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No